Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Current Molecular Medicine|April 10, 2009
Toll-like receptors and their role in hematologic malignanciesAnna Wolska, Ewa Lech-Maranda, Tadeusz RobakMini Reviews in Medicinal Chemistry|June 13, 2009
Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activityEwa Lech-Maranda, Anna Korycka, Tadeusz RobakRecent Patents on Anti-Cancer Drug Discovery|November 30, 2010
Novel systemic drugs for cutaneous T-cell lymphomaEwa Lech-Maranda, Ewa Robak, Tadeusz RobakExpert Review of Anticancer Therapy|October 15, 2010
Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemiaTadeusz Robak, Ewa Lech-Maranda, Pawel RobakMini Reviews in Medicinal Chemistry|November 6, 2007
Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activityEwa Lech-Maranda, Ewa Robak, Anna Korycka, et al.Molecules (Basel, Switzerland)|March 28, 2009
Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseasesTadeusz Robak, Anna Korycka, Ewa Lech-Maranda, et al.Current Medicinal Chemistry|December 16, 2006
Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activityTadeusz Robak, Ewa Lech-Maranda, Anna Korycka, et al.Haematologica|May 10, 2007
Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia?Ewa Lech-Maranda, Przemyslaw Juszczynski, Anna Szmigielska-Kaplon, et al.Leukemia & Lymphoma|June 20, 2007
Cladribine combined with cyclophosphamide and mitoxantrone is an active salvage therapy in advanced non-Hodgkin's lymphomaTadeusz Robak, Ewa Lech-Maranda, Agnieszka Janus, et al.European Cytokine Network|April 15, 2006
Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphomaEwa Lech-Maranda, Jacques Bienvenu, Anne-Sophie Michallet, et al.Pageof 7